These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9190921)

  • 1. Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection.
    Oxenius A; Bachmann MF; Mathis D; Benoist C; Zinkernagel RM; Hengartner H
    J Immunol; 1997 Jun; 158(12):5717-26. PubMed ID: 9190921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.
    Oxenius A; Bachmann MF; Ashton-Rickardt PG; Tonegawa S; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1995 Dec; 25(12):3402-11. PubMed ID: 8566030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection.
    Kamperschroer C; Quinn DG
    Cell Immunol; 1999 May; 193(2):134-46. PubMed ID: 10222055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
    Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
    Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
    Zeller JC; Nguyen N; Southern PJ
    Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C
    Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic MHC class I gene regulation of susceptibility to lymphocytic choriomeningitis.
    Speiser DE; Zinkernagel RM
    Thymus; 1990; 16(3-4):187-93. PubMed ID: 2293422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus.
    Eschli B; Zellweger RM; Wepf A; Lang KS; Quirin K; Weber J; Zinkernagel RM; Hengartner H
    J Virol; 2007 Nov; 81(21):11650-7. PubMed ID: 17699567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics and magnitude of virus-induced polyclonal B cell activation mediated by BCR-independent presentation of viral antigen.
    Jellison ER; Guay HM; Szomolanyi-Tsuda E; Welsh RM
    Eur J Immunol; 2007 Jan; 37(1):119-28. PubMed ID: 17163452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No essential role for tripeptidyl peptidase II for the processing of LCMV-derived T cell epitopes.
    Basler M; Groettrup M
    Eur J Immunol; 2007 Apr; 37(4):896-904. PubMed ID: 17357105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular and marginal zone B cells fail to cross-present MHC class I-restricted epitopes derived from viral particles.
    Keller SA; von Allmen CE; Hinton HJ; Bauer M; Muntwiler S; Dietmeier K; Saudan P; Bachmann MF
    J Immunol; 2009 May; 182(10):6261-6. PubMed ID: 19414779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection.
    Basler M; Lauer C; Beck U; Groettrup M
    J Immunol; 2009 Nov; 183(10):6145-50. PubMed ID: 19841190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.